Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.
about
HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa.Polymorphisms of HIV-2 integrase and selection of resistance to raltegravirThree main mutational pathways in HIV-2 lead to high-level raltegravir and elvitegravir resistance: implications for emerging HIV-2 treatment regimensCharacteristics of HIV-2 and HIV-1/HIV-2 Dually Seropositive Adults in West Africa Presenting for Care and Antiretroviral Therapy: The IeDEA-West Africa HIV-2 Cohort Study.In vitro activity of dolutegravir against wild-type and integrase inhibitor-resistant HIV-2HIV-2 integrase polymorphisms and longitudinal genotypic analysis of HIV-2 infected patients failing a raltegravir-containing regimen.G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does not.The Nucleoside Analog BMS-986001 Shows Greater In Vitro Activity against HIV-2 than against HIV-1.Phenotypic susceptibility of HIV-2 to raltegravir: integrase mutations Q148R and N155H confer raltegravir resistance.Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
P2860
Q33963958-600C0C71-6AFA-4001-97E1-EADBEF9D6BDFQ34426605-4F648AA9-3C6C-43BF-9B09-7CEFD767109AQ34428902-88CB110D-DE5D-4BDF-A742-1F61E7FE5FA4Q34793224-36CBBA6B-30DF-478E-B016-E13CB7B8E926Q35083423-501F6EFF-6799-47C6-B9CF-BD8F05BC9322Q35134947-E9AA99CF-F62B-4F45-B1FD-C4ABB1A009CAQ35206272-C5BE8A56-2451-47B2-AB03-80DD02A9FC9AQ36290647-931C503B-BE92-4F06-A4A5-840C09EE0579Q36839676-D404C271-EB1C-44E5-A856-D9AB501D1203Q40883043-8A091AD3-3FDC-4E2A-ACD2-5130B3DF6F7A
P2860
Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.
@en
Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.
@nl
type
label
Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.
@en
Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.
@nl
prefLabel
Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.
@en
Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.
@nl
P2093
P356
P1476
Dynamics of raltegravir resistance profile in an HIV type 2-infected patient.
@en
P2093
Adrian Wildfire
Bridget Ferns
Erasmus Smit
Judith Workman
Pamela Cook
Susan Graham
P304
P356
10.1089/AID.2009.0039
P577
2009-08-01T00:00:00Z